PRPF8

Pre-mRNA-processing-splicing factor 8 · Q6P2Q9 · PRPF8 on Sugi Atlas →

0 patent compounds predicted against PRPF8, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to PRPF8 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Personalized Antisense Oligonucleotide Therapy for a Single Participant With PRPH2 Mutation Associated With Retinal Dystrophy PHASE1/PHASE2ACTIVE_NOT_RECRUITING
SAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects PHASE1COMPLETED
MAD of IVT VP-001 in PRPF31 Mutation-Associated Retinal Dystrophy Subjects (Wallaby) PHASE1COMPLETED
Clinical and Genetic Findings in Patients With PRPF31-associated Retinitis Pigmentosa nanCOMPLETED
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy nanACTIVE_NOT_RECRUITING
Role of SF3B1 Mutation in Assessment of Acute and Chronic Lymphatic Leukemia nanNOT_YET_RECRUITING
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia nanRECRUITING
Association of SNPs in Long Intergenic Noncoding RNA 00511 (LINC00511) With Breast Cancer Among the Egyptian Population nanCOMPLETED
Genetic Investigation of Cancer Predisposition nanNOT_YET_RECRUITING
Exome Analysis in Hearing Impaired Patients nanUNKNOWN
SRSF2 Gene Mutation in Patients With t-MDS/AML nanCOMPLETED
Prevalence of a Non-Expressing 11B Mutation in Aka Peoples of the Central African Republic nanCOMPLETED
Identification and Characterization of Novel Non-Coding Variants That Contribute to Genetic Disorders nanCOMPLETED
Characterization of New Candidate Genes in Cases of Human Inherited Thrombocytopenia (CATCH) nanCOMPLETED
Efficacy and Safety Study of EGCG/Tocotrienol in 18 Patients With Splicing-mutation-mediated Cystic Fibrosis (CF) nanCOMPLETED
LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis nanCOMPLETED
Venous Thromboembolism in Myotonic Dystrophy Type 1 nanCOMPLETED
Identification of New FTLD Genes nanUNKNOWN
Identifying Genes and Mutations Underlying Retinitis Pigmentosa and Allied Diseases nanUNKNOWN
Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes nanRECRUITING
MiRNA223 and HMGB1 as Apredictos for Drug Resistant Epilepsy nanUNKNOWN
Patient's Derived Organoids for Drug Screening in Glioblastoma nanNOT_YET_RECRUITING
Advancing Neurogenetic Diagnoses Through Long-Read Sequencing nanNOT_YET_RECRUITING
Diagnosis and Phenotype Characterisation Using Genomics in Patients With Inherited Bone Marrow Failure (IBMDx Study) nanRECRUITING
Aberrant Splicings Due to Microsatellite Instability in Colorectal Cancer : Physiopathological and Clinical Impact nanUNKNOWN
Maternal Genes and Epimutations: Beckwith-Wiedemann Syndrome & Reproductive Risks nanRECRUITING
Study of Constitutional Platelet Disease nanUNKNOWN
Mechanisms of Cell Death in Spinal Muscular Atrophy nanCOMPLETED
Expression Pattern of HNRNPH1 and HNRNPK Genes in MPNs nanUNKNOWN
Natural History Study for Patients With Nemaline Myopathy in the UK nanACTIVE_NOT_RECRUITING

Related proteins — ESM-2 sequence neighbours (a PRPF8 binder may also engage these)

ProteinNameSimilarity
Q99PV0 1.000 Q99PV0 →
P34369 1.000 P34369 →
O14187 1.000 O14187 →
Q9SSD2 1.000 Q9SSD2 →
Q9T0I6 0.999 Q9T0I6 →
Q8T295 0.998 Q8T295 →
Q9E005 0.990 Q9E005 →
P54634 0.990 P54634 →
P36791 0.989 P36791 →
Q5MNV8 0.989 Q5MNV8 →
P28897 0.988 P28897 →
P89034 0.988 P89034 →
Q96SK2 0.988 Q96SK2 →
Q9CQA8 0.988 Q9CQA8 →
P23456 0.988 P23456 →
Q80930 0.987 Q80930 →
PHKB Phosphorylase kinase beta subunit 0.987 landscape →
O61608 0.987 O61608 →
Q80WL2 0.987 Q80WL2 →
Q9YQR5 0.987 Q9YQR5 →
Q3ZN07 0.987 Q3ZN07 →
Q806Y6 0.986 Q806Y6 →
P33334 0.986 P33334 →
Q5GT42 0.986 Q5GT42 →
Q84294 0.986 Q84294 →
Q9VR99 0.986 Q9VR99 →
Q9BXB7 0.986 Q9BXB7 →
M9RZ95 0.986 M9RZ95 →
P53938 0.986 P53938 →
E9PVB5 0.986 E9PVB5 →